Skip Navigation LinksHome > March 2013 - Volume 29 - Issue 2 > Bacterial infections of the small intestine
Current Opinion in Gastroenterology:
doi: 10.1097/MOG.0b013e32835b422c
SMALL INTESTINE: Edited by David H. Alpers and William F. Stenson

Bacterial infections of the small intestine

Hodges, Kima; Hecht, Gaila,b

Collapse Box


Purpose of review: The purpose of this study is to summarize the recent developments in small intestinal bacterial infections.

Recent findings: This review focuses on aspects of intestinal bacterial infection concerning research developments related to pathogenesis, new therapeutic agents and approaches, as well as potential new vaccine targets.

Summary: In terms of drug utilization, azithromycin was successfully used to eradicate a Shiga toxin producing Escherichia coli (enterohemorrhagic E. coli) without harmful effects. In the case of Clostridium difficile, fidaxomicin was found to be comparable to or superior to vancomycin depending on study conditions and whether there was concomitant antibiotic use. A novel research finding is the role of galectin 8, which is a danger-sensing lectin, which plays a role in targeting Salmonella for autophagy. In addition, several enteropathogenic E. coli and Shigella effectors were found to inactivate members of the nuclear factor kappa B pathway.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.